Obesity
Publisher: Wiley · ISSN 19307381 · 46 articles
- Response to “The Challenge of Dose‐Specific Comparisons in Obesity Pharmacotherapy”
- Beyond Weight Loss: A Geriatric Perspective on GLP‐1 RAs in Older Adults With Obesity
- Response to “Beyond Weight Loss: A Geriatric Perspective on GLP‐1 RAs in Older Adults With Obesity”
- From Parallel Practice to Shared Evidence: Korean Traditional Medicine in Obesity Care
-
Functional Characterization of CYP26B1 Short Isoform as a Novel Locus for Obesity in Indigenous Americans From Arizona
ABSTRACT Objective To identify heritable factors that affect BMI among Indigenous Americans, we previously conducted a genome‐wide association study using 7.9 million imputed genetic variants from 6789 participants. This study sought to...
-
Effects of Orbitofrontal Cortex tDCS on Cognitive Control in Individuals With Obesity: A Randomized Sham‐Controlled Trial
ABSTRACT Objective Neurocognitive traits can drive obesity‐related eating behaviors. The orbitofrontal cortex (OFC) integrates reward and sensory information to guide food‐related decision‐making. Here, we build on prior data in...
-
Interdisciplinary Weight Management in a Safety‐Net Health System: A Pilot Implementation Study
ABSTRACT Objective Despite the high prevalence of obesity and cardiometabolic diseases in safety‐net populations, access to intensive, evidence‐based lifestyle interventions and scalable implementation strategies remains limited. This...
-
Obesity Increases Cardiovascular Strain During Passive Whole‐Body Heat Stress in Middle‐Aged Women
ABSTRACT Objective Heat‐related mortality is greater in middle‐aged and older women, compared with age‐matched men, and in those with obesity, although the causes are unclear. Methods Thermoregulatory and cardiovascular responses were...
-
Long‐Term Impact of Bariatric Surgery and Dietary Interventions on Weight Loss, Physical Activity, and Food Preferences
ABSTRACT Objective This study aimed to examine changes in dietary intake, physical activity, appetite, and weight following laparoscopic adjustable gastric banding (LAGB), sleeve gastrectomy (SG), Roux‐en‐Y gastric bypass (RYGB), and...
- Building the Business Case for Access to Obesity Treatment
- Incretins, Mitochondrial Efficiency, and Muscle: Measure It Before We Model It
-
Weight Self‐Stigma and Food Noise During Post‐Metabolic Bariatric Surgery Weight Stability
ABSTRACT Objective Food noise has been studied with GLP‐1‐based therapies, but not with metabolic bariatric surgery (MBS), despite shared mechanisms. Data on food noise beyond initial weight loss are limited, and weight self‐stigma...
-
Incretin‐Based Therapies: A Testable Hypothesis Linking Incretin Signaling, Mitochondrial Redox, and OXPHOS Efficiency
ABSTRACT Objective Incretin‐based obesity therapies (IBTs), especially GLP‐1 receptor agonists (GLP‐1 RAs), effectively treat obesity and improve comorbidities. However, their impact on energy metabolism is unclear. A recent case of...
- GLP‐1 Receptor Agonists, Gastric Emptying, and Mechanisms of Weight Loss
- Response to “GLP‐1 Receptor Agonists, Gastric Emptying, and Mechanisms of Weight Loss”
-
Extreme Obesity (BMI ≥ 60 kg/m2) Characterization up to and Beyond 80 kg/m2 in 1,262,454 Bariatric Surgery Patients
ABSTRACT Objective This study aimed to estimate extreme obesity prevalence and association with disease burden and outcomes in patients undergoing metabolic and bariatric surgery (MBS). Methods Cross‐sectional data from the Metabolic...